Chronic Kidney Disease (CKD)

Nephrology
1
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
Epoetin Hospira ArmPhase 31 trial
Active Trials
NCT02504294Completed432Est. Jul 2016
Regeneron
RegeneronTARRYTOWN, NY
1 program
NoninterventionalN/A1 trial
Active Trials
NCT05106387Recruiting20Est. Dec 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
PfizerEpoetin Hospira Arm
RegeneronNoninterventional

Clinical Trials (2)

Total enrollment: 452 patients across 2 trials

NCT02504294PfizerEpoetin Hospira Arm

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Start: Jul 2015Est. completion: Jul 2016432 patients
Phase 3Completed
NCT05106387RegeneronNoninterventional

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

Start: Oct 2023Est. completion: Dec 202720 patients
N/ARecruiting

Related Jobs in Nephrology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 452 patients
3 companies competing in this space